“Overall, the trend is towards net loss.”

The Royal Society for the Protection of Birds comments on a study analysing the impact of climate change on Europe’s birds (BBC).

“There were no surprises in Genentech’s presentation. They had the platform and I don’t think they impressed.”

Carri Duncan, an analyst at Sal. Oppenheim in Zurich, comments on the latest instalment of the ongoing Roche / Genentech saga (Bloomberg).

“I find this troubling as I have documented several instances where pharmaceutical companies have attempted to intimidate academic critics of drugs.”

US Senator Charles Grassley comments on allegations that a Pfizer employee took photos of students protesting at drug industry links to academia, in the latest round of his battle against big pharma (NY Times).